Fuliang Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Fuliang Zhang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Chen Peng
School of Medicine, Jiangsu University, Zhenjiang 212003, China
1 shared publication - Jianing Li
College of Veterinary Medicine, Shandong Agricultural University, Tai’an 271018, China
1 shared publication - Jianzhu Liu
College of Veterinary Medicine, Shandong Agricultural University, Tai’an 271018, China
1 shared publication - Muzi Li
College of Veterinary Medicine, Shandong Agricultural University, Tai’an 271018, China
1 shared publication - Pimiao Zheng
Research Center for Animal Disease Control Engineering, Shandong Agricultural University, Tai’an 271018, China
1 shared publication - Qi Zheng
College of Veterinary Medicine, Shandong Agricultural University, Tai’an 271018, China
1 shared publication
Latest Publications
- Open Access
Characteristics and Key Genetic Pathway Analysis of Cr(VI)-Resistant Bacillus subtilis Isolated from Contaminated Soil in Response to Cr(VI)
With increasing industrialization, hexavalent chromium (Cr(VI)) is used in various metal smelting and other industries, which, in turn, causes hexavalent chromium pollution. This study aimed to investigate the characteristics of isolated Bacillus subtilis (B. subtilis) from high-Cr(VI) soils and to evaluate its safety. Genomic and transcriptomic analyses were performed to explore its Cr(VI) response mechanisms, and a mouse model (24 mice) was established to evaluate the safety of the bacterium at different concentrations. Key genetic findings showed that Cr(VI) exposure significantly up-regulated the Spx gene and down-regulated the CtsR gene—two critical transcriptional regulators involved in stress response and development that mediate Cr(VI) tolerance. Pathway analysis revealed that ribosome RNA, redox balance, protein biosynthesis, metabolism, and cysteine biosynthesis play a significant role in bacterial Cr(VI) resistance. In the in vivo experiment, it was observed that the small intestine (SI), liver, and spleen of the mice remained normal without any injuries. Different levels of the F3 isolate demonstrated the ability to resist colonization by digestive juices, as observed in the SI slides. Consequently, B. subtilis can endure high levels of Cr(VI) by regulating redox process genes, which makes it a potential candidate for further research in selecting safe, tolerant, and bio-remedial isolates for Cr(VI) treatment.
Open AccessCharacteristics and Key Genetic Pathway Analysis of Cr(VI)-Resistant Bacillus subtilis Isolated from Contaminated Soil in Response to Cr(VI)
With increasing industrialization, hexavalent chromium (Cr(VI)) is used in various metal smelting and other industries, which, in turn, causes hexavalent chromium pollution. This study aimed to investigate the characteristics of isolated Bacillus subtilis (B. subtilis) from high-Cr(VI) soils and to evaluate its safety. Genomic and transcriptomic analyses were performed to explore its Cr(VI) response mechanisms, and a mouse model (24 mice) was established to evaluate the safety of the bacterium at different concentrations. Key genetic findings showed that Cr(VI) exposure significantly up-regulated the Spx gene and down-regulated the CtsR gene—two critical transcriptional regulators involved in stress response and development that mediate Cr(VI) tolerance. Pathway analysis revealed that ribosome RNA, redox balance, protein biosynthesis, metabolism, and cysteine biosynthesis play a significant role in bacterial Cr(VI) resistance. In the in vivo experiment, it was observed that the small intestine (SI), liver, and spleen of the mice remained normal without any injuries. Different levels of the F3 isolate demonstrated the ability to resist colonization by digestive juices, as observed in the SI slides. Consequently, B. subtilis can endure high levels of Cr(VI) by regulating redox process genes, which makes it a potential candidate for further research in selecting safe, tolerant, and bio-remedial isolates for Cr(VI) treatment.